📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. (2021)

First Author: Costa RR

Attributed to: VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00430-021-00707-4

PubMed Identifier: 33870453

Publication URI: http://europepmc.org/abstract/MED/33870453

Type: Journal Article/Review

Volume: 210

Parent Publication: Medical microbiology and immunology

Issue: 2-3

ISSN: 0300-8584